Art: Marchesini, 2007, Courtesy of www.ginagallery.com

Ms. Nili Lesnik
Chief Executive Officer, Aurum Group

Prior to joining Aurum in 2012, Nili was leading the major campaigns in Europe and Australia for Elbit Land and C4I Division in Elbit Systems Ltd. (NASDAQ: ESLT), a Multi-Domestic Defense Electronics Company. In addition, she served as a consultant for the subsidiary companies in Elbit Systems Group providing high level commercial support with emphasis on cutting-edge procurement methods that were assimilated in local and international marketing business processes.

In 2006 Nili completed 16 years of service in the IAF, retiring as a Lieutenant colonel. She held numerous professional positions in the IAF Budget Department including the Head of Planning & Economics Division and as the Head of Sales Division. Nili holds a B.A. in Economics and a M.Sc. in Industrial Engineering & Management from Ben-Gurion University.

Dr Dan Gelvan
Managing Director of Life Sciences

Dr. Dan Gelvan is a seasoned life-science executive who before joining Aurum Ventures managed GammaCan International, Inc., a development-stage pharmaceutical company. Previously, Dr Gelvan founded and managed Zetiq Technologies, a drug discovery company specializing in cell-based high-throughput screening for novel anti-cancer drugs. Dr Gelvan founded Zetiq after leaving a senior position in Clal (Israel) Ltd., one of Israel's largest holding conglomerates. Dr Gelvan holds a PhD in Business Economics from RUC in Denmark, and a BA and MA in Economics from the Hebrew University in Jerusalem. Dan is an experienced lecturer of corporate finance and entrepreneurship. Dr Gelvan was a member of Israel's National Committee for Biotechnology for an extended period of time.

Nir Dror

Nir Dror joined Aurum Ventures in 2013. Nir brings with him over 10 years of experience in finance, including investment banking and private equity experience. Nir is actively involved in due diligence, value assessment, financial engineering, transactions and M&A activities. Nir works closely with the portfolio companies on all financial issues.

Prior to joining Aurum, Nir served as the Chief Investment Officer at Origo Investments, a $350mm investment fund. Previously, Nir worked as an associate at Barclays Capital (formerly Lehman Brothers) where he was responsible for global transactions such as M&As, debt restructuring, and IPOs.

Nir holds a Bachelor degree in Law and Accounting from Tel Aviv University, Master degree in Commercial Law from Tel Aviv University and an MBA (cum laude) from the Michigan Ross School of Business.

Ilan Lior
General Counsel

Ilan Lior joined Aurum in 2014. He handles all legal matters relating to the Aurum group of companies, the various investment transactions and supports the portfolio companies on various legal issues.

Prior to joining Aurum, Ilan was a partner in a boutique law firm where he headed the corporate and commercial practice group and advised clients on issues such as corporate financing and restructurings, joint ventures and M&A activities. He also worked extensively on matters of licensing agreements, purchase agreements and arrangements relating to intellectual property. In his work, Ilan has specialized in cross-border cases and represented a wide range of clients ranging from start-ups and other privately held companies, public enterprises, municipal bodies and governmental agencies, with special expertise in international infrastructure tenders.

Ilan is a member of the Israel Bar Association since 1998. As a graduate of Tel Aviv University joint bachelor program in Law and Economics, he also holds a B.A. in Economics.